Roche inks Nvidia deal to bolster AI factory, speed up drug and diagnostic development

FierceBiotechChutes & Ladders—Astellas appoints new top strategist from Sanofi Japan

FierceBiotechLigand tries to disembark from part of Viking pact, alleging contract breach

CellBringing the genetically minimal cell to life on a computer in 4D

IlluminaCanaccord cuts Illumina stock price target on competition concerns - Investing.com

Endpoints NewsSeaport, Hemab price IPOs, while Avalyn soars in Nasdaq debut

Thermo FisherIs Thermo Fisher’s New U.S. Bioprocess Design Center Shaping a Deeper Biopharma Strategy for TMO? - simplywall.st

Endpoints NewsJ&J axes pair of CAR-T therapies for lymphoma, citing evolving market

Endpoints NewsBoehringer appoints pharma veteran for corporate affairs post; BlueRock CSO heads for the exit

Novo NordiskA proposal seeks to remove Novo and Lilly drugs from key list in the US – will provide better protection against copies - medwatch.com

FierceBiotechAmgen abandons candidates for cancer, Sjögren’s syndrome over weak ph. 2 data

AmgenAmgen abandons candidates for cancer, Sjögren’s syndrome over weak ph. 2 data - Fierce Biotech

Samsung Biologics(LEAD) Samsung Biologics union launches 1st general strike over pay dispute - Yonhap News Agency